5% Lidocaine Medicated Plaster in Elderly Patients with Postherpetic Neuralgia: Results of a Compassionate Use Programme in France

By Clère Florentin  

Drugs & Aging, Vol. 28, Iss. 9, 2011-09 ,pp. : 693-702

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of a Lidocaine 5% Medicated Plaster Compared with Pregabalin for the Treatment of Postherpetic Neuralgia in the UK: A Markov Model Analysis

By Ritchie Mark  

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 71-87

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of a Lidocaine 5% Medicated Plaster Compared with Gabapentin and Pregabalin for Treating Postherpetic Neuralgia: A German Perspective

By Liedgens Hiltrud  

Clinical Drug Investigation, Vol. 28, Iss. 9, 2008-01 ,pp. : 583-601

Adis International

Access to resources Recommend Favorite

Topical 5% Lidocaine (Lignocaine) Medicated Plaster Treatment for Post-Herpetic Neuralgia: Results of a Double-Blind, Placebo-Controlled, Multinational Efficacy and Safety Trial

By Binder Andreas  

Clinical Drug Investigation, Vol. 29, Iss. 6, 2009-05 ,pp. : 393-408

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic Polyneuropathy: Interim Analysis from an Open-Label, Two-Stage Adaptive, Randomized, Controlled Trial

By Baron Ralf  

Clinical Drug Investigation, Vol. 29, Iss. 4, 2009-01 ,pp. : 231-241

Adis International

Access to resources Recommend Favorite